Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abhishek Thavamani

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Plos One|April 27, 2013
EGFR mutations in Indian lung cancer patients: clinical correlation and outcome to EGFR targeted therapyVanita Noronha, Kumar Prabhash, Abhishek Thavamani, et al.
Plos One|October 15, 2013
Frequency of EGFR mutations in 907 lung adenocarcioma patients of Indian ethnicityAnuradha Chougule, Kumar Prabhash, Vanita Noronha, et al.
Analytical Chemistry|July 24, 2024
Sensitive Multiplexed MicroRNA Spatial Profiling and Data Classification Framework Applied to Murine Breast TumorsOmar N Mohd, Yujing J Heng, Lin Wang, et al.
Cancers|January 12, 2021
Serum Response Factor (SRF) Drives the Transcriptional Upregulation of the MDM4 Oncogene in HCCRossella Pellegrino, Abhishek Thavamani, Diego F Calvisi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2019
Identification of Ppar<i>γ</i>-modulated miRNA hubs that target the fibrotic tumor microenvironmentIvana Winkler, Catrin Bitter, Sebastian Winkler, et al.
Hepatology (Baltimore, Md.)|October 1, 2014
Dysregulated serum response factor triggers formation of hepatocellular carcinomaStefan Ohrnberger, Abhishek Thavamani, Albert Braeuning, et al.
Cell Reports|October 12, 2022
PARP-inhibition reprograms macrophages toward an anti-tumor phenotypeLin Wang, Dan Wang, Olmo Sonzogni, et al.
Research Square|January 30, 2023
Reciprocal inhibition of PIN1 and APC/C<sub>CDH1</sub> controls timely G1/S transition and creates therapeutic vulnerabilityShizhong Ke, Fabin Dang, Lin Wang, et al.
Nature Communications|April 15, 2024
Reciprocal antagonism of PIN1-APC/C<sup>CDH1</sup> governs mitotic protein stability and cell cycle entryShizhong Ke, Fabin Dang, Lin Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|September 26, 2025
Masculinizing Testosterone Therapy Reduces the Incidence of PIK3CA-Mutant/ER⁺ Breast Cancer but Not BRCA1-Associated Triple-Negative Breast CancerLin Wang, Brian R Sardella, Abhishek Thavamani, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Plos One|April 27, 2013
EGFR mutations in Indian lung cancer patients: clinical correlation and outcome to EGFR targeted therapyVanita Noronha, Kumar Prabhash, Abhishek Thavamani, et al.
Plos One|October 15, 2013
Frequency of EGFR mutations in 907 lung adenocarcioma patients of Indian ethnicityAnuradha Chougule, Kumar Prabhash, Vanita Noronha, et al.
Analytical Chemistry|July 24, 2024
Sensitive Multiplexed MicroRNA Spatial Profiling and Data Classification Framework Applied to Murine Breast TumorsOmar N Mohd, Yujing J Heng, Lin Wang, et al.
Cancers|January 12, 2021
Serum Response Factor (SRF) Drives the Transcriptional Upregulation of the MDM4 Oncogene in HCCRossella Pellegrino, Abhishek Thavamani, Diego F Calvisi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2019
Identification of Ppar<i>γ</i>-modulated miRNA hubs that target the fibrotic tumor microenvironmentIvana Winkler, Catrin Bitter, Sebastian Winkler, et al.
Hepatology (Baltimore, Md.)|October 1, 2014
Dysregulated serum response factor triggers formation of hepatocellular carcinomaStefan Ohrnberger, Abhishek Thavamani, Albert Braeuning, et al.
Cell Reports|October 12, 2022
PARP-inhibition reprograms macrophages toward an anti-tumor phenotypeLin Wang, Dan Wang, Olmo Sonzogni, et al.
Research Square|January 30, 2023
Reciprocal inhibition of PIN1 and APC/C<sub>CDH1</sub> controls timely G1/S transition and creates therapeutic vulnerabilityShizhong Ke, Fabin Dang, Lin Wang, et al.
Nature Communications|April 15, 2024
Reciprocal antagonism of PIN1-APC/C<sup>CDH1</sup> governs mitotic protein stability and cell cycle entryShizhong Ke, Fabin Dang, Lin Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|September 26, 2025
Masculinizing Testosterone Therapy Reduces the Incidence of PIK3CA-Mutant/ER⁺ Breast Cancer but Not BRCA1-Associated Triple-Negative Breast CancerLin Wang, Brian R Sardella, Abhishek Thavamani, et al.
Pageof 1